LEADER 01190nlm0 22003851i 450 
001 990009482770403321
005 20120705132231.0
010   $a9780470584170$bonline
035   $a000948277
035   $aFED01000948277
035   $a(Aleph)000948277FED01
035   $a000948277
100   $a20111114d2010----km-y0itaa50------ba
101 0 $aeng
102   $aUS
105   $a--------001yy
135   $adrnn-008mamaa
200 1 $aLead Generation Approaches in Drug Discovery$bRisorsa elettronica$f[edited by] Zoran Rankovic, Richard Morphy
210   $aHoboken, N.J$cJohn Wiley & Sons$d2010
230   $aDocumento elettronico
336   $aTesto
337   $aFormato html, pdf
610 0 $aFarmaci$aRicerca
610 0 $aFarmacologia sperimentale
676   $a615.19
702  1$aRankovic,$bZoran
702  1$aMorphy,$bRichard
801  0$aIT$bUNINA$gREICAT$2UNIMARC
856 4 $zFull text per gli utenti Federico II$uhttp://onlinelibrary.wiley.com/book/10.1002/9780470584170
901   $aEB
912   $a990009482770403321
952   $a80$b10715$fFFABC
959   $aFFABC
996   $aLead Generation Approaches in Drug Discovery$9852157
997   $aUNINA

LEADER 01003nam--2200373---450-
001 990002152190203316
005 20090609172109.0
035   $a000215219
035   $aUSA01000215219
035   $a(ALEPH)000215219USA01
035   $a000215219
100   $a20041108d1981----km-y0itay0103----ba
101 0 $afre
102   $aFR
105   $a||||||||001yy
200 1 $aÉtudes offertes à René Rodière
210   $aParis$cDalloz$d1981
215   $aXXXV, 540 p.$c1 ritr.$d24 cm
410  0$12001
454  1$12001
461  1$1001-------$12001
600 1 $aRodière,$bRené
606 0 $aDiritto$xStudi
676   $a340
702  1$aRODIÈRE,$bRené
801  0$aIT$bsalbc$gISBD
912   $a990002152190203316
951   $aXXI.4. 193 (SIO B 201)$b21982 E.C.$cSIO B$d00231323
959   $aBK
969   $aGIU
979   $aSIAV4$b10$c20041108$lUSA01$h1745
979   $aRSIAV3$b90$c20090609$lUSA01$h1721
996   $aETUDES offertes a Rene Rodiere$9681280
997   $aUNISA